Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
IMIDAZOLYLPYRIMIDINE COMPOUNDS AS HDAC AND / OR CDK INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2010/009139
Kind Code:
A3
Abstract:
A compound of general Formula (I) having histone deacetylase (HDAC) and/or Cyclin- dependent kinase (CDK) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.

Inventors:
VENKATARAMANI CHANDRASEKAR (US)
Application Number:
PCT/US2009/050558
Publication Date:
July 08, 2010
Filing Date:
July 14, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GILEAD COLORADO INC (US)
VENKATARAMANI CHANDRASEKAR (US)
International Classes:
C07D403/04; A61K31/506; A61K31/53; A61P3/00; A61P25/00; C07D409/14; C07D417/14
Domestic Patent References:
WO2006064251A12006-06-22
WO2007040440A12007-04-12
Foreign References:
Other References:
PRICE S ET AL: "Histone deacetylase inhibitors: An analysis of recent patenting activity", EXPERT OPINION ON THERAPEUTIC PATENTS 200707 GB, vol. 17, no. 7, July 2007 (2007-07-01), pages 745 - 765, XP002546795, ISSN: 1354-3776
LEE M -H ET AL: "Molecular targets for cell cycle inhibition and cancer therapy", EXPERT OPINION ON THERAPEUTIC PATENTS 20030301 GB, vol. 13, no. 3, 1 March 2003 (2003-03-01), pages 329 - 346, XP002546796, ISSN: 1354-3776
Attorney, Agent or Firm:
LEE, Kisuk (Dickey & Pierce P.l.c.,7700 Bohomme, Suite 40, St. Louis MO, US)
Download PDF: